WASHINGTON, D.C. — The Cure Coalition applauds Chairman John Moolenaar (R-MI-02) of the Select Committee on China and Senator Jim Banks (R-IN) for introducing the Securing Innovation and Research from Adversaries Act. This bold, necessary legislation marks a critical step forward in safeguarding the integrity of American biomedical research and protecting the health of families across the nation.
American families rely on a fundamental promise: that taxpayer-funded innovation will be developed at home and adhere to the highest standards of quality and safety. That promise is undermined when federally funded science is exposed to exploitation by foreign adversaries who do not share our commitment to patient welfare and gold-standard research approaches.
Biomedical leadership is not merely an economic asset; it is a national security imperative. The pipeline of cures, vaccines, diagnostics, and therapies that keep America healthy must be built on a foundation of trust, transparency, and security. When foreign adversaries exploit our biomedical research, they undermine the control and confidence Americans deserve in the lifesaving medicines they rely on every day.
The Cure Coalition stands with the patients, researchers, and legislators who are counting on a secure, U.S.-led biomedical enterprise. This bill sends an important message of commitment to dependable research, and we thank Chairman Moolenaar and Senator Banks for their leadership in safeguarding the health and safety of American families.
About Cure Coalition
Cure Coalition advocates for responsible, evidence-based biomedical research that keeps our families safe and keeps trusted U.S. research approaches as the standard. As mothers, healthcare professionals, and concerned citizens, we’re committed to advancing treatments and cures through medicines Americans can count on. Learn more at curecoalition.org.